Study Identifies 'Kill Switch' Mechanism That Stops Galaxy Growth at Critical Mass
Astronomers using a large cosmological simulation have identified a mechanism that halts star formation in galaxies once they reach a critical mass of roughly 10^12.5 solar masses. The research proposes that a stable halo of hot gas forms around massive galaxies, preventing cool gas from falling in and fueling new star formation. This finding provides a testable explanation for why even the most prolific star-forming galaxies eventually stop growing, a phenomenon astronomers have observed but not fully understood.
A new study led by Preetish Mishra of the Korea Institute for Advanced Study proposes that galaxies have a physical 'kill switch' that stops their growth at a specific mass threshold. Using the Horizon Run 5 simulation—one of the largest cosmological models ever created—researchers tracked roughly 20,000 massive galaxies from shortly after the Big Bang to present day. They found that galaxies below 10^12.4 to 10^12.7 solar masses efficiently convert infalling gas into stars, but above this critical mass, star formation efficiency drops by more than a factor of three. The mechanism appears to be the formation of a hot gas halo that reaches gravitational equilibrium, preventing cool gas from cooling quickly enough to fall inward and feed star formation. The study also ruled out competing explanations involving matter loss from supernovas and black hole activity, finding these account for less than 30 percent of the observed decline. While the simulation-based results are promising and passed sensitivity tests, the precise numerical values could shift as modeling techniques improve.
What's missing
The article does not discuss how this finding relates to observations of real galaxies or whether existing astronomical data supports the predicted critical mass threshold. Additionally, there is limited discussion of the broader implications for understanding galaxy evolution and the role of supermassive black holes in galaxy quenching.
How coverage differed
Space.com presents the research in straightforward scientific terms, emphasizing the novelty of the proposed mechanism and the robustness of the simulation-based evidence. The source balances enthusiasm for the findings with appropriate caveats about simulation limitations, reflecting standard science journalism practice.
What different sources said
- Space.comCenter
Do galaxies have a 'kill switch' that makes them stop growing?
Related
Researchers Identify Small Molecule Inhibitors Targeting ILT3 Protein as Potential Alzheimer's Disease Treatment
Scientists discovered small molecule compounds that inhibit ILT3 (LILRB4), a protein that suppresses immune cell activity in the brain and contributes to Alzheimer's disease pathology. ILT3 is an emerging neuroimmune checkpoint that restricts microglial activation and amyloid clearance through ApoE-dependent signaling. The findings suggest ILT3 inhibition could be a viable therapeutic approach, as targeting it improved cognition and reduced amyloid burden in mouse models.
Study Reveals Distinct T Cell Receptor Patterns Between Melanoma Tumors and Lymph Nodes
Researchers sequenced T cell receptors from 24 melanoma patients' primary tumors and sentinel lymph nodes, finding markedly different immune cell populations between the two sites. The tumor sites showed reduced diversity but pronounced clonal dominance, suggesting selective expansion of tumor-fighting T cells with features associated with recognizing patient-specific cancer antigens. These findings provide insights into how anti-tumor immunity is spatially organized and could inform immunotherapy development.
Study Reveals How Chromosomal Rearrangement Drives Gene Activation in Mantle Cell Lymphoma
Researchers discovered that the characteristic chromosomal translocation in mantle cell lymphoma (MCL) creates abnormal interactions between chromosome 19 and a rearranged region on chromosome 14, leading to widespread gene activation. This interchromosomal contact pattern appears to be a key mechanism driving the disease's specific gene expression profile. The findings suggest that targeting these spatial genome reorganizations could offer new therapeutic approaches for MCL treatment.